SUMMARY / ABSTRACT
blasts is altered, revealing disease-associated gene networks. We also identified a core set of 12 transcription factors that were co-activated in blasts, which suggests a joint transcription standard genomic procedures that require at least 100'000 cells [9] [10] [11] . This is exemplified by Figure 1A and B, see the Materials and Methods). As expected, the number of 10 detected genes per cell was comparable between the conditions and variable between the cells 11 [19, 20] (Figure 1 ). On average, 1764 transcribed genes were detected per cell (RPKM > 10).
12
Consistent with previous reports [19] [20] [21] , we observed a substantial variability in the cell-to-13 cell transcriptome (Pearson 0.0007 < r < 1, mean 0.57) ( Figure 1C ). Bulk RNA from each 14 individual was prepared for bulk-to-single cell transcriptome correlations. As described, the 15 bulk transcriptomes were highly correlated with the single-cell transcriptomes (Pearson 0.38 < 16 r < 0.89, mean 0.63) ( Figure 1C ), thus supporting the assumption that bulk samples reflect the 17 average of single-cell populations [20, 22] . transcripts identified 625 genes that presented significant changes (p-value < 0.05) (refer to 24 the supplementary data, Table S1 ). As expected, the hierarchical clustering map of the 25 differentially expressed transcripts showed two distinct cell populations ( Figure 2A ). An 1 analysis of the gene ontology terms conducted on this set of differentially expressed 2 transcripts revealed significantly enriched terms associated with the genes mainly implicated 3 in the NOD-like receptor pathway (e.g., CXCL2, CXCL8, NLRP3, and TRAF6) ( Figure 2B ).
4
This term also includes chemokines that are critical for the survival and proliferation of 5 cancer cells, such as CXC-motif ligand 8 (CXCL8, IL-8) [23, 24] . RNASEH2A) were activated in those cells, whereas the nucleotide excision repair pathway 10 was significantly downregulated, thus suggesting a promoted DNA damage ( Figure 2B ), 11 which was previously described in quiescent cells [25] [26] [27] . A gene set enrichment analysis
12
(GSEA) was performed to evaluate the presence of well-characterized stem cell regulatory 13 genes in our dataset ( Figure 2C ). We tested predefined gene lists from published gene 14 expression profiles of pathways activated in LSCs and HSCs (refer to the supplementary data, 15   Table S4 ) [11, 12, 28, 29] and confirmed that the stem-associated genes expressed by our Figure 2C ).
20
The network map illustrates the functional connectivity among the differentially expressed 21 genes ( Figure 2D functional-related gene groups in the two AML cells revealed common properties of LSCs in
13
"stemness"-related signaling pathways that control survival, tumorigenesis and self-renewal.
14
The patients with AML1 and AML2 belonged to different subtypes of AML. with non-AML and AML1 cells (refer to the supplementary data, Figure S6 ). The pathways 23 deregulated by this overexpression, i.e., RAS, ERK, AKT, TGF-beta, and GPCR, are 24 illustrated in the networking map ( Figure 5A ). A comparison with the cellular network map 25 from the AML1 sample showed that these perturbations were specific for AML2
blasts ( Figure 5A ). following the manufacturer's protocol.
17
For all of the samples, the cDNA quality was assessed on a 2100 Bioanalyzer (Agilent) using 18 high sensitivity DNA chips (Agilent). Subsequently, the cDNA was quantified using a Qubit 
The following GENCODE categories were considered for the study: TR genes, IG genes, rates were evaluated using a univariate Cox regression models (p-value < 0.05). The hazard 8 ratio was reported in comparison to the gene low-expression group. The survival curves were 9 visualized using Kaplan-Meier plots. 
20
The authors declare no financial conflict of interests. 
10
The correlation coefficient is also colored according to the scale ranging from 1.0 (blue) to - placed by default into cluster 1. proportion to the number of differentially expressed genes enriched for the labelled TFBs. 
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